Maternal and neonatal outcome in early- and late-onset pre-eclampsia

Seminars in Neonatology

Volumn 5, Issue 3, 2000, Pages 197-207

  Paruk, F ^a   Moodley, J ^a  

^a UNIVERSITY OF NATAL   (South Africa)

Author keywords

Early onset pre eclampsia; Late onset pre eclampsia; Maternal morbidity; Maternal mortality; Neonatal outcome; Perinatal morbidity; Perinatal mortality

Indexed keywords

CORTICOSTEROID; DIHYDRALAZINE; KETANSERIN; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE;

BRAIN HEMORRHAGE; CONSERVATIVE TREATMENT; ECLAMPSIA; FETUS MORTALITY; HELLP SYNDROME; HYPERTENSION; MATERNAL MORBIDITY; PREECLAMPSIA; PREGNANCY COMPLICATION; PRENATAL DIAGNOSIS; RESPIRATORY DISTRESS SYNDROME; REVIEW; RISK ASSESSMENT;

EID: 0033811706     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.2000.0023     Document Type: Article

References (78)

1. The classification of hypertensive disorders of pregnancy
2. Management of hypertension in pregnancy
3. Randomised trial of management of hypertensive pregnancies by Korotkoff phase IV or phase V
4. Treatment of hypertensive crises
5. Hypertensive encephalopathies
6. Management of pre-eclampsia and the HELLP Syndrome
7. Maternal and perinatal outcome of conservative management of severe pre-eclampsia in the mid-trimester
8. Fetal and neonatal outcome in patients with severe pre-eclampsia before 34 weeks
9. Expectant management of early onset of severe pre-eclampsia in Durban, South Africa
10. The management of severe toxaemia in patients at less than 36 weeks gestation
11. A protocol for managing severe pre-eclampsia in the second trimester
12. Aggressive versus expectant management of severe pre-eclampsia at 28-32 weeks gestation: A randomised controlled trial
13. Aggressive or expectant management for patients with severe pre-eclampsia between 28-34 weeks gestation: A randomised controlled trial
14. Management of severe early onset pre-eclampsia: Is conservative management justified?
15. The mortality and morbidity associated with very preterm pre-eclampsia
16. HELLP syndrome: Incidence and maternal fetal outcome: A prospective study
17. The HELLP syndrome (haemolysis, elevated liver enzymes and low platelets): Much ado about nothing?
18. Neonatal outcome in severe pre-eclampsia at 24-36 weeks gestation: Does the HELLP (haemolysis, elevated liver enzymes and low platelet count) syndrome matter?
19. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with pre-eclampsia without HELLP syndrome
20. Temporising management of severe pre-eclampsia with and without the HELLE syndrome
21. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial
22. A comparison of magnesium sulphate with phenytoin for the prevention of eclampsia
23. Treatment of hypertension in pregnancy
24. Final report of study on hypertension during pregnancy
25. Magnesium sulphate in the treatment of eclampsia and pre-eclampsia: An overview of the evidence from randomised trials
26. Can magnesium sulphate reduce the risk of cerebral palsy in very low birth weight infants?
27. Any antihypertensive therapy for pregnancy
28. Maternal deaths from neurological complications of hypertensive crises in pregnancy
29. Effect of dihydralazine on the fetus in the treatment of hypertension in pregnancy
30. Nifedipine in acute hypertensive emergencies in pregnancy
31. Nifedipine in the treatment of severe pre-eclampsia
32. Magnesium plus nifedipine potentiation of hypotensive effect in pre-eclampsia?
33. Calcium channel blockers and myocardial infarction. A hypothesis formulated but not yet tested
34. Spinning the risks and benefits of calcium antagonists
35. Managing high blood pressure in pregnancy
36. Ketanserin and hydralazine in hypertension in pregnancy - A randomised double blind trial
37. Fetal outcome in a trial of antihypertensive treatment in pregnancy
38. Factors relevant to mode of preterm delivery with syndrome of HELLP
39. Mode of delivery in pregnancies complicated by pre-eclampsia with very low birth weight infants
40. Neonatal outcome after preterm delivery for pre-eclampsia
41. Severe pre-eclampsia in preterm pregnancy between 26 and 32 weeks gestation
42. Neonatal outcome of premature infants of mothers with pre-eclampsia
43. Prenatal events and the risk of subependymal/intravaentricular haemorrhage in very low birth weight neonates
44. Maternal toxaemia is associated with reduced incidence of germinal matrix hemorrhage in premature babies
45. Case controlled study of antenatal and intrapartum risk factors for cerebral palsy in very preterm singleton babies
46. Two year infant neurodevelopmental outcome after expectant management and indicated preterm delivery in hypertensive pregnancies
47. Some observations on the incidence of pre-eclampsia
48. Eclampsia I: Observations from 67 recent cases
49. The association of maternal and neonatal thrombocytopenia in high risk pregnancies
50. Coagulation changes in eclampsia: Their frequency and pathogenesis
51. Hypertension in pregnancy
52. Pregnancy outcome in 303 cases with severe preeclampsia
53. Syndrome of haemolysis, elevated liver enzymes and low platelet counts: A severe consequence of hypertension in pregnancy
54. Spontaneous resolution of pre-eclampsia related thrombocytopenia
55. Maternal perinatal outcome associated with the syndrome of haemolysis, elevated liver enzymes and low platelets in severe pre-eclampsia-eclampsia
56. HELLP syndrome - A syndrome of haemolysis, elevated liver enzymes and low platelet count - Complicating pre-eclampsia-eclampsia
57. The natural history of HELLP syndrome: Patterns of disease progression and regression
58. Maternal and perinatal outcome associated with hypertensive crises of pregnancy
59. Maternal mortality rates in eclampsia
60. Maternal deaths associated with hypertensive disorders of pregnancy
61. Eclampsia
62. Eclampsia - A continuing problem in the developing world
63. Reproductive performance after eclampsia
64. The familial factor in toxaemia of pregnancy
65. Eclampsia VII. Pregnancy outcome after eclampsia and long-term prognosis
66. The remote prognosis of eclamptic women. Sixth periodical report
67. Hypertension in pregnancy: The incidence of underlying renal disease and essential hypertension
68. A prospective controlled five-year follow-up study of primiparas with gestational hypertension
69. Severe pre-eclampsia-eclampsia in young primigravid women: Subsequent pregnancy outcome and remote prognosis
70. What happens to women with pre-eclampsia? Microalbuminura and hypertension following pre-eclampsia
71. Pre-eclampsia/eclampsia with haemolysis, elevated liver enzymes and thrombocytopenia
72. Perinatal outcome of babies born to Black South African women with hypertension
73. Eclampsia in the United Kingdom
74. Correlates of placental abruption
75. Perinatal outcome in abruptio placentae
76. Pre-eclampsia and offspring's blood pressure, cognitive ability and physical development at 17 years of age
77. The laboratory evaluation of hypertensive gravidas
78. Predictive value of plasma thrombomodulin in pre-eclampsia and gestational hypertension